世界のB細胞慢性リンパ性白血病治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-3892 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、B細胞慢性リンパ性白血病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（AMG-319、ATTCK-20、IDD-002、JNJ-64052781、レナリドマイド、MAT-303、MT-3724、その他）、用途別市場規模（診療所、病院、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・B細胞慢性リンパ性白血病治療の市場動向 ・企業の競争状況、市場シェア ・B細胞慢性リンパ性白血病治療の種類別市場規模と予測2016-2027（AMG-319、ATTCK-20、IDD-002、JNJ-64052781、レナリドマイド、MAT-303、MT-3724、その他） ・B細胞慢性リンパ性白血病治療の用途別市場規模と予測2016-2027（診療所、病院、その他） ・B細胞慢性リンパ性白血病治療の北米市場規模2016-2027（アメリカ、カナダ） ・B細胞慢性リンパ性白血病治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・B細胞慢性リンパ性白血病治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・B細胞慢性リンパ性白血病治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・B細胞慢性リンパ性白血病治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（AB Science SA、Amgen Inc.、Celgene Corporation、Dynavax Technologies Corporation、Eisai、Elsalys Biotech SAS、F. Hoffmann-La Roche Ltd.、iDD biotech SAS、Immunomedics, Inc.、Johnson & Johnson、Juno Therapeutics Inc.、Molecular Templates Inc.、Noxxon Pharma AG） ・結論

Market Analysis and Insights: Global B-Cell Chronic Lymphocytic Leukemia Treatment Market
The global B-Cell Chronic Lymphocytic Leukemia Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global B-Cell Chronic Lymphocytic Leukemia Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global B-Cell Chronic Lymphocytic Leukemia Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global B-Cell Chronic Lymphocytic Leukemia Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global B-Cell Chronic Lymphocytic Leukemia Treatment market.

Global B-Cell Chronic Lymphocytic Leukemia Treatment Scope and Market Size
B-Cell Chronic Lymphocytic Leukemia Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global B-Cell Chronic Lymphocytic Leukemia Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
AMG-319
ATTCK-20
IDD-002
JNJ-64052781
Lenalidomide
MAT-303
MT-3724
Others

Segment by Application
Clinic
Hospital
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AB Science SA
Amgen Inc.
Celgene Corporation
Dynavax Technologies Corporation
Eisai
Elsalys Biotech SAS
F. Hoffmann-La Roche Ltd.
iDD biotech SAS
Immunomedics, Inc.
Johnson & Johnson
Juno Therapeutics Inc.
Molecular Templates Inc.
Noxxon Pharma AG

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 AMG-319
1.2.3 ATTCK-20
1.2.4 IDD-002
1.2.5 JNJ-64052781
1.2.6 Lenalidomide
1.2.7 MAT-303
1.2.8 MT-3724
1.2.9 Others
1.3 Market by Application
1.3.1 Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Perspective (2016-2027)
2.2 B-Cell Chronic Lymphocytic Leukemia Treatment Growth Trends by Regions
2.2.1 B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 B-Cell Chronic Lymphocytic Leukemia Treatment Historic Market Share by Regions (2016-2021)
2.2.3 B-Cell Chronic Lymphocytic Leukemia Treatment Forecasted Market Size by Regions (2022-2027)
2.3 B-Cell Chronic Lymphocytic Leukemia Treatment Industry Dynamic
2.3.1 B-Cell Chronic Lymphocytic Leukemia Treatment Market Trends
2.3.2 B-Cell Chronic Lymphocytic Leukemia Treatment Market Drivers
2.3.3 B-Cell Chronic Lymphocytic Leukemia Treatment Market Challenges
2.3.4 B-Cell Chronic Lymphocytic Leukemia Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top B-Cell Chronic Lymphocytic Leukemia Treatment Players by Revenue
3.1.1 Global Top B-Cell Chronic Lymphocytic Leukemia Treatment Players by Revenue (2016-2021)
3.1.2 Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share by Players (2016-2021)
3.2 Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by B-Cell Chronic Lymphocytic Leukemia Treatment Revenue
3.4 Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Concentration Ratio
3.4.1 Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by B-Cell Chronic Lymphocytic Leukemia Treatment Revenue in 2020
3.5 B-Cell Chronic Lymphocytic Leukemia Treatment Key Players Head office and Area Served
3.6 Key Players B-Cell Chronic Lymphocytic Leukemia Treatment Product Solution and Service
3.7 Date of Enter into B-Cell Chronic Lymphocytic Leukemia Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 B-Cell Chronic Lymphocytic Leukemia Treatment Breakdown Data by Type
4.1 Global B-Cell Chronic Lymphocytic Leukemia Treatment Historic Market Size by Type (2016-2021)
4.2 Global B-Cell Chronic Lymphocytic Leukemia Treatment Forecasted Market Size by Type (2022-2027)

5 B-Cell Chronic Lymphocytic Leukemia Treatment Breakdown Data by Application
5.1 Global B-Cell Chronic Lymphocytic Leukemia Treatment Historic Market Size by Application (2016-2021)
5.2 Global B-Cell Chronic Lymphocytic Leukemia Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America B-Cell Chronic Lymphocytic Leukemia Treatment Market Size (2016-2027)
6.2 North America B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Type
6.2.1 North America B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Type (2016-2021)
6.2.2 North America B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Type (2022-2027)
6.2.3 North America B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Type (2016-2027)
6.3 North America B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Application
6.3.1 North America B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Application (2016-2021)
6.3.2 North America B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Application (2022-2027)
6.3.3 North America B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Application (2016-2027)
6.4 North America B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Country
6.4.1 North America B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Country (2016-2021)
6.4.2 North America B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe B-Cell Chronic Lymphocytic Leukemia Treatment Market Size (2016-2027)
7.2 Europe B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Type
7.2.1 Europe B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Type (2016-2021)
7.2.2 Europe B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Type (2022-2027)
7.2.3 Europe B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Type (2016-2027)
7.3 Europe B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Application
7.3.1 Europe B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Application (2016-2021)
7.3.2 Europe B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Application (2022-2027)
7.3.3 Europe B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Application (2016-2027)
7.4 Europe B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Country
7.4.1 Europe B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Country (2016-2021)
7.4.2 Europe B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific B-Cell Chronic Lymphocytic Leukemia Treatment Market Size (2016-2027)
8.2 Asia-Pacific B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Type
8.2.1 Asia-Pacific B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Application
8.3.1 Asia-Pacific B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Region
8.4.1 Asia-Pacific B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America B-Cell Chronic Lymphocytic Leukemia Treatment Market Size (2016-2027)
9.2 Latin America B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Type
9.2.1 Latin America B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Type (2016-2021)
9.2.2 Latin America B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Type (2022-2027)
9.2.3 Latin America B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Type (2016-2027)
9.3 Latin America B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Application
9.3.1 Latin America B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Application (2016-2021)
9.3.2 Latin America B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Application (2022-2027)
9.3.3 Latin America B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Application (2016-2027)
9.4 Latin America B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Country
9.4.1 Latin America B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Country (2016-2021)
9.4.2 Latin America B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa B-Cell Chronic Lymphocytic Leukemia Treatment Market Size (2016-2027)
10.2 Middle East & Africa B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Type
10.2.1 Middle East & Africa B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Application
10.3.1 Middle East & Africa B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Country
10.4.1 Middle East & Africa B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AB Science SA
11.1.1 AB Science SA Company Details
11.1.2 AB Science SA Business Overview
11.1.3 AB Science SA B-Cell Chronic Lymphocytic Leukemia Treatment Introduction
11.1.4 AB Science SA Revenue in B-Cell Chronic Lymphocytic Leukemia Treatment Business (2016-2021)
11.1.5 AB Science SA Recent Development
11.2 Amgen Inc.
11.2.1 Amgen Inc. Company Details
11.2.2 Amgen Inc. Business Overview
11.2.3 Amgen Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Introduction
11.2.4 Amgen Inc. Revenue in B-Cell Chronic Lymphocytic Leukemia Treatment Business (2016-2021)
11.2.5 Amgen Inc. Recent Development
11.3 Celgene Corporation
11.3.1 Celgene Corporation Company Details
11.3.2 Celgene Corporation Business Overview
11.3.3 Celgene Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Introduction
11.3.4 Celgene Corporation Revenue in B-Cell Chronic Lymphocytic Leukemia Treatment Business (2016-2021)
11.3.5 Celgene Corporation Recent Development
11.4 Dynavax Technologies Corporation
11.4.1 Dynavax Technologies Corporation Company Details
11.4.2 Dynavax Technologies Corporation Business Overview
11.4.3 Dynavax Technologies Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Introduction
11.4.4 Dynavax Technologies Corporation Revenue in B-Cell Chronic Lymphocytic Leukemia Treatment Business (2016-2021)
11.4.5 Dynavax Technologies Corporation Recent Development
11.5 Eisai
11.5.1 Eisai Company Details
11.5.2 Eisai Business Overview
11.5.3 Eisai B-Cell Chronic Lymphocytic Leukemia Treatment Introduction
11.5.4 Eisai Revenue in B-Cell Chronic Lymphocytic Leukemia Treatment Business (2016-2021)
11.5.5 Eisai Recent Development
11.6 Elsalys Biotech SAS
11.6.1 Elsalys Biotech SAS Company Details
11.6.2 Elsalys Biotech SAS Business Overview
11.6.3 Elsalys Biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Introduction
11.6.4 Elsalys Biotech SAS Revenue in B-Cell Chronic Lymphocytic Leukemia Treatment Business (2016-2021)
11.6.5 Elsalys Biotech SAS Recent Development
11.7 F. Hoffmann-La Roche Ltd.
11.7.1 F. Hoffmann-La Roche Ltd. Company Details
11.7.2 F. Hoffmann-La Roche Ltd. Business Overview
11.7.3 F. Hoffmann-La Roche Ltd. B-Cell Chronic Lymphocytic Leukemia Treatment Introduction
11.7.4 F. Hoffmann-La Roche Ltd. Revenue in B-Cell Chronic Lymphocytic Leukemia Treatment Business (2016-2021)
11.7.5 F. Hoffmann-La Roche Ltd. Recent Development
11.8 iDD biotech SAS
11.8.1 iDD biotech SAS Company Details
11.8.2 iDD biotech SAS Business Overview
11.8.3 iDD biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Introduction
11.8.4 iDD biotech SAS Revenue in B-Cell Chronic Lymphocytic Leukemia Treatment Business (2016-2021)
11.8.5 iDD biotech SAS Recent Development
11.9 Immunomedics, Inc.
11.9.1 Immunomedics, Inc. Company Details
11.9.2 Immunomedics, Inc. Business Overview
11.9.3 Immunomedics, Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Introduction
11.9.4 Immunomedics, Inc. Revenue in B-Cell Chronic Lymphocytic Leukemia Treatment Business (2016-2021)
11.9.5 Immunomedics, Inc. Recent Development
11.10 Johnson & Johnson
11.10.1 Johnson & Johnson Company Details
11.10.2 Johnson & Johnson Business Overview
11.10.3 Johnson & Johnson B-Cell Chronic Lymphocytic Leukemia Treatment Introduction
11.10.4 Johnson & Johnson Revenue in B-Cell Chronic Lymphocytic Leukemia Treatment Business (2016-2021)
11.10.5 Johnson & Johnson Recent Development
11.11 Juno Therapeutics Inc.
11.11.1 Juno Therapeutics Inc. Company Details
11.11.2 Juno Therapeutics Inc. Business Overview
11.11.3 Juno Therapeutics Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Introduction
11.11.4 Juno Therapeutics Inc. Revenue in B-Cell Chronic Lymphocytic Leukemia Treatment Business (2016-2021)
11.11.5 Juno Therapeutics Inc. Recent Development
11.12 Molecular Templates Inc.
11.12.1 Molecular Templates Inc. Company Details
11.12.2 Molecular Templates Inc. Business Overview
11.12.3 Molecular Templates Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Introduction
11.12.4 Molecular Templates Inc. Revenue in B-Cell Chronic Lymphocytic Leukemia Treatment Business (2016-2021)
11.12.5 Molecular Templates Inc. Recent Development
11.13 Noxxon Pharma AG
11.13.1 Noxxon Pharma AG Company Details
11.13.2 Noxxon Pharma AG Business Overview
11.13.3 Noxxon Pharma AG B-Cell Chronic Lymphocytic Leukemia Treatment Introduction
11.13.4 Noxxon Pharma AG Revenue in B-Cell Chronic Lymphocytic Leukemia Treatment Business (2016-2021)
11.13.5 Noxxon Pharma AG Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of AMG-319
Table 3. Key Players of ATTCK-20
Table 4. Key Players of IDD-002
Table 5. Key Players of JNJ-64052781
Table 6. Key Players of Lenalidomide
Table 7. Key Players of MAT-303
Table 8. Key Players of MT-3724
Table 9. Key Players of Others
Table 10. Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 12. Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 13. Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Share by Regions (2016-2021)
Table 14. Global B-Cell Chronic Lymphocytic Leukemia Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 15. Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Share by Regions (2022-2027)
Table 16. B-Cell Chronic Lymphocytic Leukemia Treatment Market Trends
Table 17. B-Cell Chronic Lymphocytic Leukemia Treatment Market Drivers
Table 18. B-Cell Chronic Lymphocytic Leukemia Treatment Market Challenges
Table 19. B-Cell Chronic Lymphocytic Leukemia Treatment Market Restraints
Table 20. Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 21. Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Share by Players (2016-2021)
Table 22. Global Top B-Cell Chronic Lymphocytic Leukemia Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in B-Cell Chronic Lymphocytic Leukemia Treatment as of 2020)
Table 23. Ranking of Global Top B-Cell Chronic Lymphocytic Leukemia Treatment Companies by Revenue (US$ Million) in 2020
Table 24. Global 5 Largest Players Market Share by B-Cell Chronic Lymphocytic Leukemia Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players B-Cell Chronic Lymphocytic Leukemia Treatment Product Solution and Service
Table 27. Date of Enter into B-Cell Chronic Lymphocytic Leukemia Treatment Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 30. Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share by Type (2016-2021)
Table 31. Global B-Cell Chronic Lymphocytic Leukemia Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 32. Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 33. Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 34. Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share by Application (2016-2021)
Table 35. Global B-Cell Chronic Lymphocytic Leukemia Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 36. Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 37. North America B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. North America B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. North America B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. North America B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. North America B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. North America B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Europe B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Europe B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Europe B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Europe B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Europe B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 48. Europe B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 49. Asia-Pacific B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Asia-Pacific B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Asia-Pacific B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Asia-Pacific B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Asia-Pacific B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 54. Asia-Pacific B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 55. Latin America B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Latin America B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Latin America B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Latin America B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Latin America B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Latin America B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. Middle East & Africa B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Type (2016-2021) (US$ Million)
Table 62. Middle East & Africa B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 63. Middle East & Africa B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Application (2016-2021) (US$ Million)
Table 64. Middle East & Africa B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 65. Middle East & Africa B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 66. Middle East & Africa B-Cell Chronic Lymphocytic Leukemia Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 67. AB Science SA Company Details
Table 68. AB Science SA Business Overview
Table 69. AB Science SA B-Cell Chronic Lymphocytic Leukemia Treatment Product
Table 70. AB Science SA Revenue in B-Cell Chronic Lymphocytic Leukemia Treatment Business (2016-2021) & (US$ Million)
Table 71. AB Science SA Recent Development
Table 72. Amgen Inc. Company Details
Table 73. Amgen Inc. Business Overview
Table 74. Amgen Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Product
Table 75. Amgen Inc. Revenue in B-Cell Chronic Lymphocytic Leukemia Treatment Business (2016-2021) & (US$ Million)
Table 76. Amgen Inc. Recent Development
Table 77. Celgene Corporation Company Details
Table 78. Celgene Corporation Business Overview
Table 79. Celgene Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Product
Table 80. Celgene Corporation Revenue in B-Cell Chronic Lymphocytic Leukemia Treatment Business (2016-2021) & (US$ Million)
Table 81. Celgene Corporation Recent Development
Table 82. Dynavax Technologies Corporation Company Details
Table 83. Dynavax Technologies Corporation Business Overview
Table 84. Dynavax Technologies Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Product
Table 85. Dynavax Technologies Corporation Revenue in B-Cell Chronic Lymphocytic Leukemia Treatment Business (2016-2021) & (US$ Million)
Table 86. Dynavax Technologies Corporation Recent Development
Table 87. Eisai Company Details
Table 88. Eisai Business Overview
Table 89. Eisai B-Cell Chronic Lymphocytic Leukemia Treatment Product
Table 90. Eisai Revenue in B-Cell Chronic Lymphocytic Leukemia Treatment Business (2016-2021) & (US$ Million)
Table 91. Eisai Recent Development
Table 92. Elsalys Biotech SAS Company Details
Table 93. Elsalys Biotech SAS Business Overview
Table 94. Elsalys Biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Product
Table 95. Elsalys Biotech SAS Revenue in B-Cell Chronic Lymphocytic Leukemia Treatment Business (2016-2021) & (US$ Million)
Table 96. Elsalys Biotech SAS Recent Development
Table 97. F. Hoffmann-La Roche Ltd. Company Details
Table 98. F. Hoffmann-La Roche Ltd. Business Overview
Table 99. F. Hoffmann-La Roche Ltd. B-Cell Chronic Lymphocytic Leukemia Treatment Product
Table 100. F. Hoffmann-La Roche Ltd. Revenue in B-Cell Chronic Lymphocytic Leukemia Treatment Business (2016-2021) & (US$ Million)
Table 101. F. Hoffmann-La Roche Ltd. Recent Development
Table 102. iDD biotech SAS Company Details
Table 103. iDD biotech SAS Business Overview
Table 104. iDD biotech SAS Revenue in B-Cell Chronic Lymphocytic Leukemia Treatment Business (2016-2021) & (US$ Million)
Table 105. iDD biotech SAS Recent Development
Table 106. Immunomedics, Inc. Company Details
Table 107. Immunomedics, Inc. Business Overview
Table 108. Immunomedics, Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Product
Table 109. Immunomedics, Inc. Revenue in B-Cell Chronic Lymphocytic Leukemia Treatment Business (2016-2021) & (US$ Million)
Table 110. Immunomedics, Inc. Recent Development
Table 111. Johnson & Johnson Company Details
Table 112. Johnson & Johnson Business Overview
Table 113. Johnson & Johnson B-Cell Chronic Lymphocytic Leukemia Treatment Product
Table 114. Johnson & Johnson Revenue in B-Cell Chronic Lymphocytic Leukemia Treatment Business (2016-2021) & (US$ Million)
Table 115. Johnson & Johnson Recent Development
Table 116. Juno Therapeutics Inc. Company Details
Table 117. Juno Therapeutics Inc. Business Overview
Table 118. Juno Therapeutics Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Product
Table 119. Juno Therapeutics Inc. Revenue in B-Cell Chronic Lymphocytic Leukemia Treatment Business (2016-2021) & (US$ Million)
Table 120. Juno Therapeutics Inc. Recent Development
Table 121. Molecular Templates Inc. Company Details
Table 122. Molecular Templates Inc. Business Overview
Table 123. Molecular Templates Inc. B-Cell Chronic Lymphocytic Leukemia Treatment Product
Table 124. Molecular Templates Inc. Revenue in B-Cell Chronic Lymphocytic Leukemia Treatment Business (2016-2021) & (US$ Million)
Table 125. Molecular Templates Inc. Recent Development
Table 126. Noxxon Pharma AG Company Details
Table 127. Noxxon Pharma AG Business Overview
Table 128. Noxxon Pharma AG B-Cell Chronic Lymphocytic Leukemia Treatment Product
Table 129. Noxxon Pharma AG Revenue in B-Cell Chronic Lymphocytic Leukemia Treatment Business (2016-2021) & (US$ Million)
Table 130. Noxxon Pharma AG Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Share by Type: 2020 VS 2027
Figure 2. AMG-319 Features
Figure 3. ATTCK-20 Features
Figure 4. IDD-002 Features
Figure 5. JNJ-64052781 Features
Figure 6. Lenalidomide Features
Figure 7. MAT-303 Features
Figure 8. MT-3724 Features
Figure 9. Others Features
Figure 10. Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Share by Application: 2020 VS 2027
Figure 11. Clinic Case Studies
Figure 12. Hospital Case Studies
Figure 13. Others Case Studies
Figure 14. B-Cell Chronic Lymphocytic Leukemia Treatment Report Years Considered
Figure 15. Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 16. Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Share by Regions: 2020 VS 2027
Figure 18. Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Share by Regions (2022-2027)
Figure 19. Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Share by Players in 2020
Figure 20. Global Top B-Cell Chronic Lymphocytic Leukemia Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in B-Cell Chronic Lymphocytic Leukemia Treatment as of 2020
Figure 21. The Top 10 and 5 Players Market Share by B-Cell Chronic Lymphocytic Leukemia Treatment Revenue in 2020
Figure 22. Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share by Type (2016-2021)
Figure 23. Global B-Cell Chronic Lymphocytic Leukemia Treatment Revenue Market Share by Type (2022-2027)
Figure 24. North America B-Cell Chronic Lymphocytic Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. North America B-Cell Chronic Lymphocytic Leukemia Treatment Market Share by Type (2016-2027)
Figure 26. North America B-Cell Chronic Lymphocytic Leukemia Treatment Market Share by Application (2016-2027)
Figure 27. North America B-Cell Chronic Lymphocytic Leukemia Treatment Market Share by Country (2016-2027)
Figure 28. United States B-Cell Chronic Lymphocytic Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Canada B-Cell Chronic Lymphocytic Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe B-Cell Chronic Lymphocytic Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe B-Cell Chronic Lymphocytic Leukemia Treatment Market Share by Type (2016-2027)
Figure 32. Europe B-Cell Chronic Lymphocytic Leukemia Treatment Market Share by Application (2016-2027)
Figure 33. Europe B-Cell Chronic Lymphocytic Leukemia Treatment Market Share by Country (2016-2027)
Figure 34. Germany B-Cell Chronic Lymphocytic Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. France B-Cell Chronic Lymphocytic Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. U.K. B-Cell Chronic Lymphocytic Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Italy B-Cell Chronic Lymphocytic Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Russia B-Cell Chronic Lymphocytic Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Nordic B-Cell Chronic Lymphocytic Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific B-Cell Chronic Lymphocytic Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific B-Cell Chronic Lymphocytic Leukemia Treatment Market Share by Type (2016-2027)
Figure 42. Asia-Pacific B-Cell Chronic Lymphocytic Leukemia Treatment Market Share by Application (2016-2027)
Figure 43. Asia-Pacific B-Cell Chronic Lymphocytic Leukemia Treatment Market Share by Region (2016-2027)
Figure 44. China B-Cell Chronic Lymphocytic Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Japan B-Cell Chronic Lymphocytic Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. South Korea B-Cell Chronic Lymphocytic Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Southeast Asia B-Cell Chronic Lymphocytic Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. India B-Cell Chronic Lymphocytic Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Australia B-Cell Chronic Lymphocytic Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America B-Cell Chronic Lymphocytic Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America B-Cell Chronic Lymphocytic Leukemia Treatment Market Share by Type (2016-2027)
Figure 52. Latin America B-Cell Chronic Lymphocytic Leukemia Treatment Market Share by Application (2016-2027)
Figure 53. Latin America B-Cell Chronic Lymphocytic Leukemia Treatment Market Share by Country (2016-2027)
Figure 54. Mexico B-Cell Chronic Lymphocytic Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Brazil B-Cell Chronic Lymphocytic Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa B-Cell Chronic Lymphocytic Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa B-Cell Chronic Lymphocytic Leukemia Treatment Market Share by Type (2016-2027)
Figure 58. Middle East & Africa B-Cell Chronic Lymphocytic Leukemia Treatment Market Share by Application (2016-2027)
Figure 59. Middle East & Africa B-Cell Chronic Lymphocytic Leukemia Treatment Market Share by Country (2016-2027)
Figure 60. Turkey B-Cell Chronic Lymphocytic Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Saudi Arabia B-Cell Chronic Lymphocytic Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. UAE B-Cell Chronic Lymphocytic Leukemia Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. AB Science SA Revenue Growth Rate in B-Cell Chronic Lymphocytic Leukemia Treatment Business (2016-2021)
Figure 64. Amgen Inc. Revenue Growth Rate in B-Cell Chronic Lymphocytic Leukemia Treatment Business (2016-2021)
Figure 65. Celgene Corporation Revenue Growth Rate in B-Cell Chronic Lymphocytic Leukemia Treatment Business (2016-2021)
Figure 66. Dynavax Technologies Corporation Revenue Growth Rate in B-Cell Chronic Lymphocytic Leukemia Treatment Business (2016-2021)
Figure 67. Eisai Revenue Growth Rate in B-Cell Chronic Lymphocytic Leukemia Treatment Business (2016-2021)
Figure 68. Elsalys Biotech SAS Revenue Growth Rate in B-Cell Chronic Lymphocytic Leukemia Treatment Business (2016-2021)
Figure 69. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in B-Cell Chronic Lymphocytic Leukemia Treatment Business (2016-2021)
Figure 70. iDD biotech SAS Revenue Growth Rate in B-Cell Chronic Lymphocytic Leukemia Treatment Business (2016-2021)
Figure 71. Immunomedics, Inc. Revenue Growth Rate in B-Cell Chronic Lymphocytic Leukemia Treatment Business (2016-2021)
Figure 72. Johnson & Johnson Revenue Growth Rate in B-Cell Chronic Lymphocytic Leukemia Treatment Business (2016-2021)
Figure 73. Juno Therapeutics Inc. Revenue Growth Rate in B-Cell Chronic Lymphocytic Leukemia Treatment Business (2016-2021)
Figure 74. Molecular Templates Inc. Revenue Growth Rate in B-Cell Chronic Lymphocytic Leukemia Treatment Business (2016-2021)
Figure 75. Noxxon Pharma AG Revenue Growth Rate in B-Cell Chronic Lymphocytic Leukemia Treatment Business (2016-2021)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed

---